These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26054719)

  • 1. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
    Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
    Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.
    Seillet C; Jackson JT; Markey KA; Brady HJ; Hill GR; Macdonald KP; Nutt SL; Belz GT
    Blood; 2013 Feb; 121(9):1574-83. PubMed ID: 23297132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.
    Edelson BT; KC W; Juang R; Kohyama M; Benoit LA; Klekotka PA; Moon C; Albring JC; Ise W; Michael DG; Bhattacharya D; Stappenbeck TS; Holtzman MJ; Sung SS; Murphy TL; Hildner K; Murphy KM
    J Exp Med; 2010 Apr; 207(4):823-36. PubMed ID: 20351058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFIL3/E4BP4 is a key transcription factor for CD8α⁺ dendritic cell development.
    Kashiwada M; Pham NL; Pewe LL; Harty JT; Rothman PB
    Blood; 2011 Jun; 117(23):6193-7. PubMed ID: 21474667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development.
    Jaiswal H; Kaushik M; Sougrat R; Gupta M; Dey A; Verma R; Ozato K; Tailor P
    J Immunol; 2013 Dec; 191(12):5993-6001. PubMed ID: 24227775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells.
    Bar-On L; Birnberg T; Lewis KL; Edelson BT; Bruder D; Hildner K; Buer J; Murphy KM; Reizis B; Jung S
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14745-50. PubMed ID: 20679228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory dendritic cell development mediated by BATF-IRF interactions.
    Tussiwand R; Lee WL; Murphy TL; Mashayekhi M; KC W; Albring JC; Satpathy AT; Rotondo JA; Edelson BT; Kretzer NM; Wu X; Weiss LA; Glasmacher E; Li P; Liao W; Behnke M; Lam SS; Aurthur CT; Leonard WJ; Singh H; Stallings CL; Sibley LD; Schreiber RD; Murphy KM
    Nature; 2012 Oct; 490(7421):502-7. PubMed ID: 22992524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Batf3 selectively determines acquisition of CD8
    Chandra J; Kuo PT; Hahn AM; Belz GT; Frazer IH
    Immunol Cell Biol; 2017 Feb; 95(2):215-223. PubMed ID: 27897162
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
    Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K
    Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow.
    Schlitzer A; Sivakamasundari V; Chen J; Sumatoh HR; Schreuder J; Lum J; Malleret B; Zhang S; Larbi A; Zolezzi F; Renia L; Poidinger M; Naik S; Newell EW; Robson P; Ginhoux F
    Nat Immunol; 2015 Jul; 16(7):718-28. PubMed ID: 26054720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batf3-dependent CD8α
    Li Y; Liu X; Duan W; Tian H; Zhu G; He H; Yao S; Yi S; Song W; Tang H
    EBioMedicine; 2017 Apr; 18():188-198. PubMed ID: 28411140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
    Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
    Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
    Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
    Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function.
    la Sala A; He J; Laricchia-Robbio L; Gorini S; Iwasaki A; Braun M; Yap GS; Sher A; Ozato K; Kelsall B
    J Exp Med; 2009 Jun; 206(6):1227-35. PubMed ID: 19487420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization.
    Edelson BT; Bradstreet TR; KC W; Hildner K; Herzog JW; Sim J; Russell JH; Murphy TL; Unanue ER; Murphy KM
    PLoS One; 2011; 6(10):e25660. PubMed ID: 22065991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
    Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
    J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
    Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
    J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells.
    Kretzer NM; Theisen DJ; Tussiwand R; Briseño CG; Grajales-Reyes GE; Wu X; Durai V; Albring J; Bagadia P; Murphy TL; Murphy KM
    J Exp Med; 2016 Dec; 213(13):2871-2883. PubMed ID: 27899443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.